Enhanced production of di-(2-ethylhexyl) phthalate (DEHP) by Bacillus subtilis AD35 using response surface methodology (RSM)

References

• Lotfy WA, Mostafa SW, Adel AA, et al. Production of di-(2-ethylhexyl) phthalate by Bacillus subtilis AD35: Isolation, purification, characterization and biological activities. Microb Pathog. 2018;124:89–100.
   PubMed Web of Science ®Google Scholar
• WHO. Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis. Geneva: WHO; 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/258965/WHO-EMP-IAU-2017.11-eng.pdf;jsessionid=705615951D7018500631F482E1447740?sequence=1.
   Google Scholar
• Todorova S, Kozhuharova L. Characteristics and antimicrobial activity of Bacillus subtilis strains isolated from soil. World J Microbiol Biotechnol. 2010;26:1207–1216.
   PubMed Web of Science ®Google Scholar
• Stein T. Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol Microbiol. 2005;56:845–857.
   PubMed Web of Science ®Google Scholar
• Moita C, Feio SS, Nunes L, et al. Optimisation of physical factors on the production of active metabolites by Bacillus subtilis 355 against wood surface contaminant fungi. Int Biodeter Biodeg. 2005;55:261–269.
   Web of Science ®Google Scholar
• Grahovac J, Rončević Z, Tadijan I, et al. Optimization of media for antimicrobial compounds production by Bacillus subtilis. Acta Aliment. 2015;44:427–435.
   Web of Science ®Google Scholar
• El-Banna NM. Effect of carbon source on the antimicrobial activity of the air flora. World J Microbiol Biotechnol. 2005;21:1451–1454.
   Web of Science ®Google Scholar
• El-Banna NM, Quddoumi SS. Effect of nitrogen source on the antimicrobial activity of the bacilli air flora. Ann Microbiol. 2007;57:669–671.
   Web of Science ®Google Scholar
• Lotfy WA, Abd-El-Karim NM, El-Sharouny EE, et al. Isolation and characterization of a haloalkaliphilic protease producer bacterium from Wadi Natrun in Egypt. Afri J Biotechnol. 2017;16:1210–1220.
   Google Scholar
• Lotfy WA, Atalla RG, Sabra WA, et al. Expression of extracellular polysaccharides and proteins by clinical isolates of Pseudomonas aeruginosa in response to environmental conditions. Int Microbiol. 2018;21:129–142.
   PubMed Web of Science ®Google Scholar
• Lotfy WA, Ghanem KM, Ehab R. Citric acid production by a novel Aspergillus niger isolate: II. Optimization of process parameters through statistical experimental designs. Bioresour Technol. 2006;11:32–40.
   Google Scholar
• Sharon SFB, Daniel RR, Shenbagarathai R. Optimization of antibiotic production by marine actinomycetes Streptomyces sp. KOD10 S. Int J Pharm Sci. 2014;6:506–510.
   Google Scholar
• Plackett RL, Burman JP. The design of optimum multifactorial experiments. Biometrika 1946;33:305–325.
   Web of Science ®Google Scholar
• Yu X, Hallett S, Sheppard J, et al. Application of the Plackett-Burman experimental design to evaluate nutritional requirements for the production of Colletotrichum coccodes spores. Appl Microbiol Biotechnol. 1997;47:301–305.
   Web of Science ®Google Scholar
• Box GE, Behnken DW. Some new three level designs for the study of quantitative variables. Technometrics 1960;2:455–475.
   Google Scholar
• Ashengroph M, Saedi D. Optimization of selenite removal by Lactobacillus sp. Tra cheese 6 using Box-Behnken design. J Kerman Univ Med Sci. 2016;23:466–482.
   Google Scholar
• Khan MN, Lin H, Li M, et al. Identification and growth optimization of a marine Bacillus DK1-SA11 having potential of producing broad spectrum antimicrobial compounds. Pak J Pharm Sci. 2017;30:839–853.
   PubMed Web of Science ®Google Scholar
• Fang X, Feng J, Zhang W, et al. Optimization of growth medium and fermentation conditions for improved antibiotic activity of Xenorhabdus nematophila TB using a statistical approach. Afri J Biotechnol. 2010;9:8068–8077.
   Web of Science ®Google Scholar
• Maxwell PW, Chen G, Webster JM, et al. Stability and activities of antibiotics produced during infection of the insect Galleria mellonella by two isolates of Xenorhabdus nematophilus. Appl Environ Microbiol. 1994;60:715–721.
   PubMed Web of Science ®Google Scholar
• Ji D, Yi Y, Kang GH, et al. Identification of an antibacterial compound, benzylideneacetone, from Xenorhabdus nematophila against major plant-pathogenic bacteria. FEMS Microbiol Lett. 2004;239:241–248.
   PubMed Web of Science ®Google Scholar
• Chen G. Antimicrobial activity of the nematode symbionts, Xenorhabdus and Photorhabdus (Enterobacteriaceae), and the discovery of two groups of antimicrobial substances, nematophin and xenorxides (PhD Thesis). Department of Biological Sciences, Simon Fraser University; Burnaby, 1996.
   Google Scholar
• Abada EA, El-Hendawy HH, Osman ME, et al. Antimicrobial activity of Bacillus circulans isolated from rhizosphere of Medicago sativa. Life Sci J. 2014;11:711–719.
   Google Scholar
• El Batal A, Mona S. Al-Tamie M. Biosynthesis of gold nanoparticles using marine Streptomyces cyaneus and their antimicrobial, antioxidant and antitumor (in vitro) activities. J Chem Pharm Res. 2015;7:1020–1036.
   Google Scholar
• Majumdar MK, Majumdar S. Utilization of carbon and nitrogen-containing compounds for neomycin production by Streptomyces fradiae. Appl Microbiol. 1967;15:744–749.
   PubMedGoogle Scholar
• Kadiri SK, Yarla NS. Optimization of antimicrobial metabolites production by Streptomyces fradiae. Int J Pharm Pharm Sci. 2016;7:223–225.
   Google Scholar
• Pandey A, Shukla A, Majumdar S. Utilization of carbon and nitrogen sources by Streptomyces kanamyceticus M 27 for the production of an antibacterial antibiotic. Afri J Biotechnol. 2005;4:909–910.
   Google Scholar
• Sujatha P, Raju KB, Ramana T. Studies on a new marine streptomycete BT-408 producing polyketide antibiotic SBR-22 effective against methicillin resistant Staphylococcus aureus. Microbiol Res. 2005;160:119–126.
   PubMedGoogle Scholar
• El-Sersy NA, Ebrahim HA, Abou-Elela GM. Response surface methodology as a tool for optimizing the production of antimicrobial agents from Bacillus licheniformis SN 2. Curr Res Bacteriol. 2010;3:1–14.
   Google Scholar
• Ji S, Li W, Xin H, et al. Improved production of sublancin 168 biosynthesized by Bacillus subtilis 168 using chemometric methodology and statistical experimental designs. BioMed Res Int. 2015;2015:1–9.
   Google Scholar
• Oman TJ, Boettcher JM, Wang H, et al. Sublancin is not a lantibiotic but an S-linked glycopeptide. Nat Chem Biol. 2011;7:78–80.
   PubMed Web of Science ®Google Scholar